IRIS Accounts Production v25.4.0.155 09943728 Board of Directors Board of Directors 1.4.24 31.3.25 31.3.25 false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh099437282024-03-31099437282025-03-31099437282024-04-012025-03-31099437282023-03-31099437282023-04-012024-03-31099437282024-03-3109943728ns15:EnglandWales2024-04-012025-03-3109943728ns14:PoundSterling2024-04-012025-03-3109943728ns10:Director12024-04-012025-03-3109943728ns10:Director22024-04-012025-03-3109943728ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3109943728ns10:SmallEntities2024-04-012025-03-3109943728ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3109943728ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3109943728ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3109943728ns10:FullAccounts2024-04-012025-03-310994372812024-04-012025-03-3109943728ns10:OrdinaryShareClass12024-04-012025-03-3109943728ns10:RegisteredOffice2024-04-012025-03-3109943728ns5:CurrentFinancialInstruments2025-03-3109943728ns5:CurrentFinancialInstruments2024-03-3109943728ns5:ShareCapital2025-03-3109943728ns5:ShareCapital2024-03-3109943728ns5:RetainedEarningsAccumulatedLosses2025-03-3109943728ns5:RetainedEarningsAccumulatedLosses2024-03-3109943728ns5:NetGoodwill2024-04-012025-03-3109943728ns5:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3109943728ns5:PlantMachinery2024-04-012025-03-3109943728ns5:FurnitureFittings2024-04-012025-03-3109943728ns5:ComputerEquipment2024-04-012025-03-3109943728ns5:NetGoodwill2024-03-3109943728ns5:NetGoodwill2025-03-3109943728ns5:NetGoodwill2024-03-3109943728ns5:PlantMachinery2024-03-3109943728ns5:FurnitureFittings2024-03-3109943728ns5:ComputerEquipment2024-03-3109943728ns5:PlantMachinery2025-03-3109943728ns5:FurnitureFittings2025-03-3109943728ns5:ComputerEquipment2025-03-3109943728ns5:PlantMachinery2024-03-3109943728ns5:FurnitureFittings2024-03-3109943728ns5:ComputerEquipment2024-03-3109943728ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3109943728ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3109943728ns10:OrdinaryShareClass12025-03-31
REGISTERED NUMBER: 09943728 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 March 2025

for

LH Clinical Research Limited

LH Clinical Research Limited (Registered number: 09943728)






Contents of the Financial Statements
for the Year Ended 31 March 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


LH Clinical Research Limited

Company Information
for the Year Ended 31 March 2025







DIRECTORS: K J Hardaker
L Hardaker





REGISTERED OFFICE: 2 Clifton Moor Business Village
James Nicolson Link
York
North Yorkshire
YO30 4XG





REGISTERED NUMBER: 09943728 (England and Wales)





ACCOUNTANTS: Beckingtons
2 Clifton Moor Business
Village
James Nicolson Link
York
North Yorkshire
YO30 4XG

LH Clinical Research Limited (Registered number: 09943728)

Balance Sheet
31 March 2025

31.3.25 31.3.24
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 3,151 2,727
3,151 2,727

CURRENT ASSETS
Debtors 6 19,125 23,835
Cash at bank 75,375 85,477
94,500 109,312
CREDITORS
Amounts falling due within one year 7 11,091 26,191
NET CURRENT ASSETS 83,409 83,121
TOTAL ASSETS LESS CURRENT
LIABILITIES

86,560

85,848

CAPITAL AND RESERVES
Called up share capital 8 2 2
Retained earnings 86,558 85,846
SHAREHOLDERS' FUNDS 86,560 85,848

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

LH Clinical Research Limited (Registered number: 09943728)

Balance Sheet - continued
31 March 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 15 December 2025 and were signed on its behalf by:




L Hardaker - Director



K J Hardaker - Director


LH Clinical Research Limited (Registered number: 09943728)

Notes to the Financial Statements
for the Year Ended 31 March 2025

1. STATUTORY INFORMATION

LH Clinical Research Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2016, is being amortised evenly over its estimated useful life of three years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance
Fixtures and fittings - 20% on reducing balance
Computer equipment - 33% on reducing balance

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 3 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2024
and 31 March 2025 10,000
AMORTISATION
At 1 April 2024
and 31 March 2025 10,000
NET BOOK VALUE
At 31 March 2025 -
At 31 March 2024 -

LH Clinical Research Limited (Registered number: 09943728)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

5. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Computer
machinery fittings equipment Totals
£    £    £    £   
COST
At 1 April 2024 2,935 1,753 9,228 13,916
Additions - 408 2,002 2,410
Disposals - (319 ) (4,972 ) (5,291 )
At 31 March 2025 2,935 1,842 6,258 11,035
DEPRECIATION
At 1 April 2024 2,055 1,180 7,954 11,189
Charge for year 220 198 1,095 1,513
Eliminated on disposal - (156 ) (4,662 ) (4,818 )
At 31 March 2025 2,275 1,222 4,387 7,884
NET BOOK VALUE
At 31 March 2025 660 620 1,871 3,151
At 31 March 2024 880 573 1,274 2,727

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Trade debtors 19,125 23,835

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Trade creditors - 120
Taxation and social security 352 18,758
Other creditors 10,739 7,313
11,091 26,191

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.25 31.3.24
value: £    £   
2 Ordinary £1 2 2